Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2024;9(1):2103.DOI: 10.25107/2474-1663-v9-id2103

Hierarchical Radical Resection of Pancreaticoduodenectomy (HRR-PD). A New Classification to Guide Operative Decisions for Cancer

Sun J, Zhang P, Lu W1 Zhang F and Wu D

Department of Hepatic & Biliary & Pancreatic Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology

*Correspondance to: Junwei Sun 

 PDF  Full Text Research Article | Open Access

Abstract:

For periampullary cancer and pancreatic head cancer, pancreaticoduodenectomy has always been a standard surgical method. The scope of its resection seems to be clear, but its detailed anatomical locations are not clearly defined. At the same time, although its surgical methods have been improving, surgical methods are constantly being redefined from the perspectives of lymph node dissection, lacunar anatomy, and mesentery. However, these improved theories are mostly mutually exclusive, cannot be thought of under a unified theoretical framework, and lack hierarchical and en bloc resection thinking. It is obvious that a single surgical resection range cannot adapt to the characteristics of cancers with different biological behaviors. Based on this, we proposed a theory of “hierarchical radical cure with pancreaticoduodenectomy”. It has three levels of surgical resection range, and this concept emphasizes the principle of block resection. It can meet the needs of different levels of resection range and ensures the principle of resection of malignant tumors.

Keywords:

Hierarchical radical resection; Pancreaticoduodenectomy; Cancer

Cite the Article:

Sun J, Zhang P, Lu W1 Zhang F and Wu D. Hierarchical Radical Resection of Pancreaticoduodenectomy (HRR-PD). A New Classification to Guide Operative Decisions for Cancer. Clin Oncol. 2024;9:2103..

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Clinical Outcome for Rectal Cancer Treated with Preoperative Chemoradiotherapy (CRT) Based on the Pathological Tumor Regression Grade (TRG)
 Abstract  PDF  Full Text
Ultrasound Strain Elastography Features in Patients with Early and Advanced Stages of Cervical Cancer
 Abstract  PDF  Full Text
View More...